The Weekly Litigation News Digest is now live. Subscribe now

Euro Celtique competitive analysis

Loading summary...

Explore Euro Celtique's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Oct 26, 2022Dosage Form Containing Oxycodone And Naloxone5
Jul 27, 2022Pharmaceutical Compositions Comprising Hydromorphone And Naloxone2
Mar 10, 2021Intranasal Pharmaceutical Dosage Forms Comprising Naloxone1
May 13, 2020A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation2
Apr 10, 2019Dosage Form Containing Oxycodone And Naloxone7
Jul 12, 2017Manufacturing Of Active-Free Granules And Tablets Comprising The Same1
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And Naloxone11
May 3, 2017Melt Extrusion Of Multiparticulates1
May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine3

Latest PTAB cases involving Euro Celtique

Discover the latest PTAB cases involving Euro Celtique, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Euro Celtique with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
EURO CELTIQUE - 44 - -
DEVELCO PHARMA SCHWEIZ5 - - -
ETHYPHARM112 - -
HEXAL SANDOZ5 - - -